pyrazines has been researched along with Cancer of Larynx in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liang, YM; Liu, H; Wang, QW; Wang, T; Zhu, XD | 1 |
Yang, X | 1 |
2 other study(ies) available for pyrazines and Cancer of Larynx
Article | Year |
---|---|
[Proteasome inhibitor bortezomib sensitizes Hep-2 human laryngeal squamous cell carcinoma cells to ionizing radiation in vitro and in vivo].
Topics: Animals; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Cell Line, Tumor; Enzyme Inhibitors; Female; Humans; Laryngeal Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Pyrazines; Radiation Tolerance; Radiation-Sensitizing Agents | 2008 |
Proteasome inhibitor bortezomi-induced the apoptosis of laryngeal squamous cell carcinoma Hep-2 cell line via disrupting redox equilibrium.
Topics: Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Carcinoma, Squamous Cell; Caspase 3; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Humans; Laryngeal Neoplasms; Membrane Potential, Mitochondrial; Oxidation-Reduction; Oxidative Stress; Proteasome Inhibitors; Pyrazines; Reactive Oxygen Species | 2012 |